BioCorRx (BICX) EBIT Margin (2011 - 2026)

BioCorRx (BICX) posted EBIT Margin of 445.61% for Q1 2026, up 75.98% sequentially from 1854.91% in Q4 2025, and up 24969.0% YoY from N/an in Q1 2025.

BioCorRx (BICX) EBIT Margin (2011 - 2026) Analysis & Trends

BioCorRx has reported EBIT Margin for 16 years, with the latest figure at 445.61% in Q1 2026.

Quarterly EBIT Margin rose 24969.0% year-over-year to 445.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 554.74% (up 310988.0% YoY) and the FY2025 annual result came in at 606.04%, up 6622377.0% from the prior year.
EBIT Margin climbed to 445.61% in Q1 2026 per BICX's latest filing, from 1854.91% in the prior quarter.
Over five years, EBIT Margin peaked at 28.38% in Q3 2025 and troughed at 33852.95% in Q2 2024.
A 5-year average of 6808.24% and a median of 2611.93% in 2023 frame the typical range for EBIT Margin.
The sharpest annual moves came in 2024 and 2025: EBIT Margin tumbled 2903044 bps in 2024, then surged 3305968 bps in 2025.
Over 5 years, EBIT Margin stood at 1430.79% in 2022, then sank by 204 bps to 4344.24% in 2023, then sank by 679 bps to 33852.95% in 2024, then jumped by 95 bps to 1854.91% in 2025, then soared by 76 bps to 445.61% in 2026.
According to Business Quant data, EBIT Margin over the past three periods registered 445.61%, 1854.91%, and 28.38% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	-12.60%
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	26.67%
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	2.10%
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	16.29%
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	8.50%
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	11.14%
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	7.66%
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	13.25%
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	18.99%
10	BioCorRx	1.49 Mn	1.47 Mn	-	-

Download Data